Pharmastem - In March 2004, Cord entered into a Patent License Agreement with the holder of patents utilized in the collection, processing, and storage of
umbilical cord blood to settle litigation against Cord for alleged patent infringements. The Patent License Agreement calls for royalties of 15% of processing
and storage revenue, with a minimum royalty of $225 per specimen collected, on all specimens collected after January 1, 2004 until the patents expire in
2010.
from a 10-Q
Someone posted this already but it was a bash. If we read the last line it clearly states that we were losing 15%.
Now we are gaining 15%